ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 51 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2016. The put-call ratio across all filers is 2.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $816,000 | -1.3% | 228,000 | +5.6% | 0.05% | -8.9% |
| Q4 2018 | $827,000 | +24.9% | 216,000 | +208.6% | 0.06% | +43.6% |
| Q3 2018 | $662,000 | -10.5% | 70,000 | -67.4% | 0.04% | -42.6% |
| Q3 2016 | $740,000 | -1.1% | 215,000 | 0.0% | 0.07% | -23.6% |
| Q2 2016 | $748,000 | -15.8% | 215,000 | 0.0% | 0.09% | -28.2% |
| Q1 2016 | $888,000 | -32.2% | 215,000 | 0.0% | 0.12% | -39.2% |
| Q3 2015 | $1,309,000 | – | 215,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
| RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
| GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
| QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
| COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
| Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
| Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
| Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
| PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |